Vioquest Pharmaceutl (VOQP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2002 | 09-2002 | 06-2002 | 12-2001 | 09-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,210 | 3,190 | 2,880 | N/A | 7 |
| Receivables | 0 | 0 | 0 | N/A | 60 |
| Inventories | 0 | 0 | 0 | N/A | 90 |
| Other current assets | 70 | 20 | 0 | 0 | 13 |
| TOTAL | $3,280 | $3,210 | $2,880 | $N/A | $170 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 350 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 7 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $357 |
| Total Assets | $3,280 | $3,210 | $2,880 | $N/A | $200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 0 | N/A | 5 |
| Accounts payable and accrued liabilities | 120 | 40 | 9 | 0 | 50 |
| Accrued Expenses | 5 | 0 | 0 | N/A | 50 |
| TOTAL | $130 | $40 | $9 | $N/A | $160 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $7 |
| Total Liabilities | $130 | $40 | $9 | $N/A | $170 |
| Shareholders' Equity | |||||
| Common Shares | 40 | 40 | 7,950 | N/A | 4,600 |
| Retained earnings | -5,100 | -5,080 | -5,070 | N/A | -4,970 |
| Other shareholders' equity | 0 | 0 | -10 | 0 | 400 |
| TOTAL | $3,150 | $3,170 | $2,870 | $N/A | $30 |
| Total Liabilities And Equity | $3,280 | $3,210 | $2,879 | $0 | $200 |